Enoxaparin
| Uses: | treatment or prophylaxis of VTE; MI? |
|---|---|
| Mechanism of action | Accelerates action of antithrombin III (ATIII), increasing its inactivation of Factor Xa. (Rang and Dale) |
| Dose | |
| Pharmacokinetics | Absorption Distribution Metabolism Elimination half-life 130–180 min; renal excretion |
| Time course of action | |
| Adverse effects | Bleeding |
No particular monitoring required